ArticleCrohn's & colitis 3602026

Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

David T Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.